NCT07132333View on ClinicalTrials.gov

Molecular Inflammation Board at the Center for Personalized Medicine

RecruitingOBSERVATIONAL
Enrollment

3,000

Participants

Timeline

Start Date

November 16, 2022

Primary Completion Date

November 30, 2032

Study Completion Date

November 30, 2032

Conditions
Psoriasis (PsO)Psoriasis ArthritisInflammatory Bowel Disease (Crohn's Disease and Ulcerative Colitis)Spondylarthropathies
Interventions
BIOLOGICAL

Biologic Agent

Intervention with biologic agents

Trial Locations (1)

72076

RECRUITING

University Hospital of Tübingen - Center for Personalized Medicine, Tübingen

All Listed Sponsors
collaborator

University Hospital Freiburg

OTHER

collaborator

University Hospital Heidelberg

OTHER

collaborator

University Hospital Ulm

OTHER

lead

University Hospital Tuebingen

OTHER